A
$ Value
$0
Shares
6,577
Price
$0
Filed
Jul 17
Insider
Name
Heeson Lee
Title
EVP, Head of Incyte Intl
CIK
0002039219
Roles
Officer
Transaction Details
Transaction Date
2025-07-15
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,577
Footnotes
Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
Filing Info
Heeson Lee's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-15 | INCY | A | $0 |
Other Insiders at INCY (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HARRIGAN EDMUND | — | — | 2026-03-31 |
|
CAGNONI PABLO J
President, Global Head of R&D
|
— | $1.8M | 2026-04-17 |
| BAKER BROS. ADVISORS LP | — | — | 2026-03-31 |
| Clancy Paul J | — | — | 2026-03-31 |
|
Meury William
Chief Executive Officer
|
— | — | 2026-04-15 |
|
Stein Steven H
CMO & Head of Late-Stage Dev.
|
— | — | 2026-04-15 |
|
Trotta Matteo
EVP, GM, Dermatology US
|
— | — | 2026-03-25 |